Exploring nanotechnology applications in Breast cancer
| bracu.degree.level | Undergraduate | |
| bracu.type.group | Student Works | |
| datacite.rights | Open Access | |
| dc.contributor.advisor | Sharmin, Sabrina | |
| dc.contributor.author | Tonima, Jannatul Ferdaus | |
| dc.contributor.author | Khan, Md. Fardin | |
| dc.contributor.department | School of Pharmacy | |
| dc.date.accessioned | 2026-06-11T10:43:30Z | |
| dc.date.available | 2026-06-11T10:43:30Z | |
| dc.date.copyright | 2025 | |
| dc.date.issued | 2025 | |
| dc.description | Cataloged from PDF version of thesis. | |
| dc.description | Includes bibliographical references (pages 46-55). | |
| dc.description | This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2025. | en_US |
| dc.description.abstract | This thesis shows and gives us an idea about the knowledge of disease biology with developments in nanoscale advances to investigate the many uses of nanotechnology in breast cancer. The study opens with a review of the pathophysiology of breast cancer, highlighting the molecular and genetic abnormalities that drive tumor development and progression. It also categorizes the main forms and clinical phases of breast cancer, providing the biological and medical background required to assess new Nano-technological treatments. Building on this framework, the thesis investigates how nanotechnology is transforming the identification, diagnosis, and management of breast cancer. It also assesses the broader advantages of nanotechnology, such as enhanced selectivity and treatment efficacy, alongside its disadvantages, including potential toxicity and production complexities. Key challenges and limitations that range from biocompatibility concerns to regulatory hurdles are critically discussed. | en_US |
| dc.description.degree | Bachelor of Pharmacy | |
| dc.description.statementofresponsibility | Jannatul Ferdaus Tonima | |
| dc.description.statementofresponsibility | Md. Fardin Khan | |
| dc.format.extent | 55 pages | |
| dc.identifier.other | ID 22346042 | |
| dc.identifier.other | ID 22346051 | |
| dc.identifier.uri | http://hdl.handle.net/10361/28365 | |
| dc.language.iso | en | en_US |
| dc.publisher | BRAC University | en_US |
| dc.rights | BRAC University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. | |
| dc.subject | Pathogenesis | en_US |
| dc.subject | Nanoparticles | en_US |
| dc.subject | Liposomes | en_US |
| dc.subject | Quantum Dots | en_US |
| dc.subject | Pathophysiology | en_US |
| dc.subject.lcsh | Nanoparticles. | |
| dc.subject.lcsh | Pathophysiology. | |
| dc.subject.lcsh | Liposomes. | |
| dc.title | Exploring nanotechnology applications in Breast cancer | en_US |
| dc.type | Thesis | en_US |